The Australian Government has launched a new $500 million investment fund to accelerate the development and commercialisation of Australian biomedical discoveries.
The Biomedical Translation Fund (BTF) is an equity co-investment venture capital program, with $250 million from the taxpayer to be dollar-matched by private sector investment.
It delivers on a major element of the National Innovation and Science Agenda, and will be administered by a BTF Committee chaired by Peter Wills.
Applications are now open until 14 September 2016.